Dressed for success? Silver impregnated nanocrystalline dressing for initial treatment of giant omphalocele
Autor: | Sonia A. Butterworth, Julia Panczuk, Amie Nowak, Candace Haddock, Vivian Ma, Dean B. Percy |
---|---|
Rok vydání: | 2018 |
Předmět: |
Male
medicine.medical_specialty Birth weight Silver sulfadiazine 03 medical and health sciences 0302 clinical medicine 030225 pediatrics medicine Initial treatment Humans Surgical Wound Infection In patient Retrospective Studies Retrospective review Omphalocele business.industry Infant Newborn Gestational age Infant General Medicine medicine.disease Bandages Silver Sulfadiazine Surgery 030220 oncology & carcinogenesis Pediatrics Perinatology and Child Health Female business Resource utilization Hernia Umbilical medicine.drug |
Zdroj: | Journal of pediatric surgery. 53(5) |
ISSN: | 1531-5037 |
Popis: | Objective The purpose of this study was to describe outcomes and resource utilization in patients treated with twice-weekly silver impregnated (SI) nanocrystalline dressings for initial non-operative management of giant omphalocele (GO). Methods A retrospective review of patients with GO treated with SI dressings was undertaken. Clinical parameters, cost, and complications were recorded. Results Five patients with GO were treated with SI dressings between 2014 and 2016. Clinical characteristic (mean ± SD) included gestational age 36 ± 4 weeks, birth weight 2.6 ± 0.63 kg, GO size 10.2 ± 4.7 cm, ventilator days 7.5 ± 8.7 d, days in NICU 41 ± 20 d, days to full feeds, 30 ± 15 d, and LOS 62 ± 41 d. The average in-hospital cost of SI dressings was $110 CAD/week. This is comparable to daily silver sulfadiazine dressings ($109CAD/week) which were used historically. All patients were discharged with once- or twice-weekly dressing changes. No ruptures occurred. There was one mortality secondary to pulmonary sepsis. Conclusions For initial non-operative management of GO, twice weekly SI nanocrystalline dressings is safe and effective. Use of SI dressings results in decreased handling of infants, reduced physician and nursing resource utilization, and favourable outcomes. Level of evidence IV (Retrospective Case Series). |
Databáze: | OpenAIRE |
Externí odkaz: |
Pro tento záznam nejsou dostupné žádné jednotky.